Noble Midstream Partners LP (NBLX) Stock Fundamental Analysis

NYSE:NBLX

15.21
-0.09 (-0.59%)
At close: May 10, 2021
15.21
0 (0%)
After Hours: 5/10/2021, 8:21:48 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

NBLX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. NBLX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, NBLX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • NBLX had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 5.11%
ROE 13%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 29.94%
PM (TTM) 18.94%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • There is no outstanding debt for NBLX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

  • NBLX has an Altman-Z score of 0.69. This is a bad value and indicates that NBLX is not financially healthy and even has some risk of bankruptcy.
  • NBLX has a Debt/Equity ratio of 0.89. This is a neutral value indicating NBLX is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • A Current Ratio of 0.25 indicates that NBLX may have some problems paying its short term obligations.
  • NBLX has a Quick Ratio of 0.25. This is a bad value and indicates that NBLX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for NBLX have decreased strongly by -12.01% in the last year.
  • Measured over the past years, NBLX shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.10% on average per year.
  • NBLX shows a small growth in Revenue. In the last year, the Revenue has grown by 6.75%.
  • NBLX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 54.15% yearly.
EPS 1Y (TTM)-12.01%
EPS 3YN/A
EPS 5Y32.1%
EPS Q2Q%-32.31%
Revenue 1Y (TTM)6.75%
Revenue growth 3YN/A
Revenue growth 5Y54.15%
Sales Q2Q%24.25%

3.2 Future

  • Based on estimates for the next years, NBLX will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.14% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-17.71%
EPS Next 2Y-11.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NBLX Yearly Revenue VS EstimatesNBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
NBLX Yearly EPS VS EstimatesNBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.61, which indicates a rather cheap valuation of NBLX.
  • The average S&P500 Price/Earnings ratio is at 27.16. NBLX is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 6.82, the valuation of NBLX can be described as very cheap.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.10, NBLX is valued rather cheaply.
Industry RankSector Rank
PE 5.61
Fwd PE 6.82
NBLX Price Earnings VS Forward Price EarningsNBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.85
NBLX Per share dataNBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • NBLX's earnings are expected to decrease with -11.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-11.14%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • NBLX has a Yearly Dividend Yield of 4.93%, which is a nice return.
  • NBLX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.93%

5.2 History

  • The dividend of NBLX decreases each year by -19.17%.
  • NBLX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-19.17%
Div Incr YearsN/A
Div Non Decr YearsN/A
NBLX Yearly Dividends per shareNBLX Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 0.5 1 1.5 2 2.5

5.3 Sustainability

  • NBLX's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-11.14%
EPS Next 3YN/A

More info and screens

Find the best dividend stocksShow peers with best dividend

Noble Midstream Partners LP

NYSE:NBLX (5/10/2021, 8:21:48 PM)

After market: 15.21 0 (0%)

15.21

-0.09 (-0.59%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)02-11
Inst Owners2.19%
Inst Owner Change0%
Ins Owners37.49%
Ins Owner Change0%
Market Cap1.37B
Revenue(TTM)818.95M
Net Income(TTM)155.13M
Analysts46.6
Price Target13.9 (-8.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.93%
Yearly Dividend0.75
Dividend Growth(5Y)-19.17%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.61
Fwd PE 6.82
P/S 1.68
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB N/A
EV/EBITDA 6.85
EPS(TTM)2.71
EY17.82%
EPS(NY)2.23
Fwd EY14.66%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.06
BVpS13.21
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.17
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 5.11%
ROE 13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 29.94%
PM (TTM) 18.94%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z 0.69
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.01%
EPS 3YN/A
EPS 5Y32.1%
EPS Q2Q%-32.31%
EPS Next Y-17.71%
EPS Next 2Y-11.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.75%
Revenue growth 3YN/A
Revenue growth 5Y54.15%
Sales Q2Q%24.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Noble Midstream Partners LP / NBLX FAQ

Can you provide the ChartMill fundamental rating for Noble Midstream Partners LP?

ChartMill assigns a fundamental rating of 4 / 10 to NBLX.


What is the valuation status of Noble Midstream Partners LP (NBLX) stock?

ChartMill assigns a valuation rating of 9 / 10 to Noble Midstream Partners LP (NBLX). This can be considered as Undervalued.


How profitable is Noble Midstream Partners LP (NBLX) stock?

Noble Midstream Partners LP (NBLX) has a profitability rating of 1 / 10.


What are the PE and PB ratios of Noble Midstream Partners LP (NBLX) stock?

The Price/Earnings (PE) ratio for Noble Midstream Partners LP (NBLX) is 5.61 and the Price/Book (PB) ratio is 1.15.


What is the expected EPS growth for Noble Midstream Partners LP (NBLX) stock?

The Earnings per Share (EPS) of Noble Midstream Partners LP (NBLX) is expected to decline by -17.71% in the next year.